Roche IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody, ATRX Rabbit Polyclonal Antibody
Roche has launched two new antibodies, the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and the ATRX Rabbit Polyclonal Antibody, to identify mutations in patients with brain cancer. The IDH1 antibody can detect the IDH1 R132H mutation in adult-type gliomas and in acute myeloid leukemia, which is associated with relatively favorable prognosis and can help stratify patients in clinical trials. The ATRX antibody detects a mutation in the ATRX gene. Both products are fully automated on Roche's BenchMark instruments and are available in the US.